CN Patent

CN106146500A — 5-氟-3-苯基-2-[(1s)-1-(9h-嘌呤-6-基氨基)丙基]-4(3h)-喹唑啉酮晶型及其制备方法

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2016-11-23 · 9y expired

What this patent protects

本发明涉及5‑氟‑3‑苯基‑2‑[(1S)‑1‑(9H‑嘌呤‑6‑基氨基)丙基]‑4(3H)‑喹唑啉酮晶型及其制备方法。该晶型的特征在于：使用Cu‑Kα射线，其X‑射线粉末衍射图谱具有下列2θ衍射角：8.018°，11.671°，17.404°，18.163°，19.980°，21.259°，23.518°，25.261°。这种晶型具有优良的特性：引湿性小，稳定性高，制备重现性好，适宜工业化规模生产。

USPTO Abstract

本发明涉及5‑氟‑3‑苯基‑2‑[(1S)‑1‑(9H‑嘌呤‑6‑基氨基)丙基]‑4(3H)‑喹唑啉酮晶型及其制备方法。该晶型的特征在于：使用Cu‑Kα射线，其X‑射线粉末衍射图谱具有下列2θ衍射角：8.018°，11.671°，17.404°，18.163°，19.980°，21.259°，23.518°，25.261°。这种晶型具有优良的特性：引湿性小，稳定性高，制备重现性好，适宜工业化规模生产。

Drugs covered by this patent

Patent Metadata

Patent number: CN106146500A
Jurisdiction: CN
Classification: —
Expires: 2016-11-23
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.